Financhill
Buy
56

RCAT Quote, Financials, Valuation and Earnings

Last price:
$6.36
Seasonality move :
-15.75%
Day range:
$6.33 - $6.92
52-week range:
$0.80 - $15.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
42.95x
P/B ratio:
21.32x
Volume:
4.7M
Avg. volume:
4.9M
1-year change:
539.62%
Market cap:
$616.4M
Revenue:
$4.9M
EPS (TTM):
-$0.71

Earnings Data

Next earnings date for RCAT
Aug 15
2025
Most recent earnings per share
-$0.27
Missed by $0.17
(May 14/2025)
Consensus Estimate
-$0.10
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RCAT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/15/2025 Q2 $7.7M -- -- -$0.12 --
05/14/2025 Q2 $12.9M -- -- -$0.07 --
05/14/2025 Q1 $2.4M $1.6M -$0.27 -$0.10 -$0.17
03/31/2025 Q1 $7.5M -- -- -$0.09 --
12/16/2024 Q4 -- $1.5M -$0.18 -- --
09/23/2024 Q3 -- $2.8M -$0.17 -- --
07/26/2024 Q2 $6.6M $6.3M -$0.09 -$0.07 -$0.02
03/18/2024 Q1 $5.8M $5.8M -$0.10 -- --
12/15/2023 Q4 -- -- -$0.10 -- --
09/19/2023 Q3 -- -- -$0.11 -- --
07/27/2023 Q2 -- -- -$0.21 -- --
03/07/2023 Q1 -- -- -$0.10 -- --
12/15/2022 Q4 -- -- -$0.12 -- --
09/12/2022 Q3 -- -- -$0.07 -- --
07/27/2022 Q2 -- -- -$0.09 -- --
03/17/2022 Q1 -- -- -$0.05 -- --
12/20/2021 Q4 -- -- -$0.05 -- --
09/20/2021 Q3 -- -- -$0.05 -- --
04/30/2021 Q2 -- -- -$0.10 -- --
01/31/2021 Q1 -- -- -$0.34 -- --
10/31/2020 Q4 -- -- -$0.04 -- --
07/31/2020 Q3 -- -- -$0.02 -- --
04/30/2020 Q2 -- -- -$0.04 -- --
01/31/2020 Q1 -- -- -$0.02 -- --
10/31/2019 Q4 -- -- -$0.01 -- --
07/31/2019 Q3 -- -- -$0.85 -- --
06/30/2019 Q2 -- -- -$1.17 -- --
03/31/2019 Q1 -- -- -$1.47 -- --
12/31/2018 Q4 -- -- -$12.00 -- --
09/30/2018 Q3 -- -- -$2.62 -- --
06/30/2018 Q2 -- -- -$2.85 -- --
03/31/2018 Q1 -- -- -- -- --
12/31/2017 Q4 -- -- -$12.00 -- --
09/30/2017 Q3 -- -- -$12.00 -- --
06/30/2017 Q2 -- -- $12.00 -- --
03/31/2017 Q1 -- -- $24.01 -- --
12/31/2016 Q4 -- -- -$108.04 -- --
09/30/2016 Q3 -- -- -$24.01 -- --
06/30/2016 Q2 -- -- -$4.95 -- --
03/31/2016 Q1 -- -- -$0.16 -- --
12/31/2015 Q4 -- -- -$3.29 -- --
09/30/2015 Q3 -- -- -$3.86 -- --
06/30/2015 Q2 -- -- -$32.89 -- --

Red Cat Holdings Earnings Questions

  • How Much did Red Cat Holdings Generate in Revenue Last Quarter?

    Red Cat Holdings reported $1.6M worth of top line sales in its most recent quarter.

  • Did Red Cat Holdings Beat Earnings Last Quarter?

    Red Cat Holdings announced earnings per share of -$0.27 which represents a miss of analyst forecast a -$0.10 per share.

  • Is Red Cat Holdings Profitable?

    Red Cat Holdings reported -$850.4K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Red Cat Holdings EPS Next Year?

    Red Cat Holdings's earnings are forecast to decrease from -$0.57 per share to -$0.40 per share next year representing a decrease of -30.7%.

  • When is Red Cat Holdings's Earnings Date?

    Red Cat Holdings's next earnings date is August 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.

Buy
64
AKRO alert for May 22

Akero Therapeutics [AKRO] is up 1.56% over the past day.

Buy
86
AGYS alert for May 22

Agilysys [AGYS] is down 1.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock